Bausch Health Companies Inc Total Assets
Bausch Health Companies Inc total assets. Based on the latest financial reports, Bausch Health Companies Inc (BHC) holds total assets worth CA$24.79 Billion CAD (≈ $17.94 Billion USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see BHC stock market capitalisation for the company's overall valuation and market capitalisation.
Total Assets of Bausch Health Companies Inc (1993–2025)
Total assets of Bausch Health Companies Inc from 1993 to 2025. This chart illustrates how Bausch Health Companies Inc's total assets have evolved over time, based on quarterly financial data. See BHC live share price for real-time trading data and today's change.
Bausch Health Companies Inc - Asset Composition Analysis
Bausch Health Companies Inc Total Assets Breakdown (December 2025)
Bausch Health Companies Inc total assets breakdown as of December 2025. Bausch Health Companies Inc's total assets of CA$24.79 Billion consist of 23.4% current assets and 76.7% non-current assets.
| Asset Category | Amount (CAD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CA$1.31 Billion | 5.0% |
| Accounts Receivable | CA$2.35 Billion | 8.9% |
| Inventory | CA$1.63 Billion | 6.2% |
| Property, Plant & Equipment | CA$2.29 Billion | 8.7% |
| Intangible Assets | CA$4.63 Billion | 17.6% |
| Goodwill | CA$11.25 Billion | 42.8% |
Asset Composition Trend (1993–2025)
This chart illustrates how Bausch Health Companies Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Bausch Health Companies Inc current assets vs equity to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Bausch Health Companies Inc's current assets represent 23.4% of total assets in 2025, a decrease from 29.2% in 1993.
- Cash Position: Cash and equivalents constituted 5.0% of total assets in 2025, down from 11.6% in 1993.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 59.0% of total assets, an increase from 4.0% in 1993.
- Asset Diversification: The largest asset category is goodwill at 42.8% of total assets.
Bausch Health Companies Inc Competitors by Total Assets
Key competitors of Bausch Health Companies Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
GALDERMA GROUP AG
NYSE:GALDY
|
USA | $13.39 Billion |
|
Takeda Pharmaceutical Company Limited
F:TKDA
|
Germany | €15.41 Trillion |
|
Galderma Group N
SW:GALD
|
Switzerland | CHF12.88 Billion |
|
Enzymatica publ AB
ST:ENZY
|
Sweden | Skr149.24 Million |
|
Shijiazhuang Yiling Pharmaceutical Co Ltd
SHE:002603
|
China | CN¥13.98 Billion |
|
Hubei Jumpcan Pharmaceutical Co Ltd
SHG:600566
|
China | CN¥17.01 Billion |
|
Kangmei Pharmaceutical Co Ltd
SHG:600518
|
China | CN¥13.68 Billion |
|
Walvax BioTech
SHE:300142
|
China | CN¥10.50 Billion |
Bausch Health Companies Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.44 | 1.31 | 0.98 |
| Quick Ratio | 1.08 | 0.98 | 0.78 |
| Cash Ratio | 0.00 | 0.35 | 0.13 |
| Working Capital | CA$1.98 Billion | CA$1.54 Billion | CA$-113.00 Million |
Bausch Health Companies Inc - Advanced Valuation Insights
This section examines the relationship between Bausch Health Companies Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 18.74 |
| Latest Market Cap to Assets Ratio | 0.12 |
| Asset Growth Rate (YoY) | -0.8% |
| Total Assets | CA$26.32 Billion |
| Market Capitalization | $3.10 Billion USD |
Valuation Analysis
Below Book Valuation: The market values Bausch Health Companies Inc's assets below their book value (0.12x), which may indicate investor concerns about asset quality or future growth.
Slight Asset Contraction: Bausch Health Companies Inc's assets decreased by 0.8% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Bausch Health Companies Inc (1993–2025)
The table below shows the annual total assets of Bausch Health Companies Inc from 1993 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | CA$26.32 Billion ≈ $19.04 Billion |
-0.77% |
| 2024-12-31 | CA$26.52 Billion ≈ $19.19 Billion |
-3.02% |
| 2023-12-31 | CA$27.35 Billion ≈ $19.78 Billion |
+6.48% |
| 2022-12-31 | CA$25.69 Billion ≈ $18.58 Billion |
-12.04% |
| 2021-12-31 | CA$29.20 Billion ≈ $21.12 Billion |
-6.40% |
| 2020-12-31 | CA$31.20 Billion ≈ $22.57 Billion |
-7.87% |
| 2019-12-31 | CA$33.86 Billion ≈ $24.50 Billion |
+23.38% |
| 2018-12-31 | CA$27.45 Billion ≈ $19.85 Billion |
-26.80% |
| 2017-12-31 | CA$37.50 Billion ≈ $27.12 Billion |
-13.86% |
| 2016-12-31 | CA$43.53 Billion ≈ $31.49 Billion |
-11.10% |
| 2015-12-31 | CA$48.96 Billion ≈ $35.42 Billion |
+85.80% |
| 2014-12-31 | CA$26.35 Billion ≈ $19.06 Billion |
-5.78% |
| 2013-12-31 | CA$27.97 Billion ≈ $20.23 Billion |
+55.82% |
| 2012-12-31 | CA$17.95 Billion ≈ $12.99 Billion |
+36.59% |
| 2011-12-31 | CA$13.14 Billion ≈ $9.51 Billion |
+21.74% |
| 2010-12-31 | CA$10.80 Billion ≈ $7.81 Billion |
+422.25% |
| 2009-12-31 | CA$2.07 Billion ≈ $1.50 Billion |
+27.32% |
| 2008-12-31 | CA$1.62 Billion ≈ $1.17 Billion |
-8.90% |
| 2007-12-31 | CA$1.78 Billion ≈ $1.29 Billion |
-18.06% |
| 2006-12-31 | CA$2.18 Billion ≈ $1.57 Billion |
-0.60% |
| 2005-12-31 | CA$2.19 Billion ≈ $1.58 Billion |
+8.74% |
| 2004-12-31 | CA$2.01 Billion ≈ $1.46 Billion |
+4.65% |
| 2003-12-31 | CA$1.92 Billion ≈ $1.39 Billion |
+4.85% |
| 2002-12-31 | CA$1.83 Billion ≈ $1.33 Billion |
+37.73% |
| 2001-12-31 | CA$1.33 Billion ≈ $963.17 Million |
+20.25% |
| 2000-12-31 | CA$1.11 Billion ≈ $800.98 Million |
+74.35% |
| 1999-12-31 | CA$635.10 Million ≈ $459.42 Million |
+217.71% |
| 1998-12-31 | CA$199.90 Million ≈ $144.60 Million |
+113.34% |
| 1997-12-31 | CA$93.70 Million ≈ $67.78 Million |
+59.90% |
| 1996-12-31 | CA$58.60 Million ≈ $42.39 Million |
-3.78% |
| 1995-12-31 | CA$60.90 Million ≈ $44.05 Million |
+137.89% |
| 1994-12-31 | CA$25.60 Million ≈ $18.52 Million |
+9.87% |
| 1993-12-31 | CA$23.30 Million ≈ $16.85 Million |
-- |
About Bausch Health Companies Inc
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmac… Read more